| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0007 |
| mRNA | tigecycline | CTRPv2 | pan-cancer | AAC | 0.17 | 0.0008 |
| mRNA | RG-108 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.001 |
| mRNA | CAY10618 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | AZD0530 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.001 |
| mRNA | MG-132 | CTRPv2 | pan-cancer | AAC | 0.2 | 0.001 |
| mRNA | selumetinib:BRD-A02303741 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.12 | 0.001 |
| mRNA | purmorphamine | CTRPv2 | pan-cancer | AAC | 0.13 | 0.001 |
| mRNA | BRD-K80183349 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | CD-437 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.002 |